Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Gemcitabine SR by Sustained Therapeutics for Transitional Cell Carcinoma (Urothelial Cell Carcinoma): Likelihood of Approval
Gemcitabine SR is under clinical development by Sustained Therapeutics and currently in Phase III for Transitional Cell Carcinoma (Urothelial Cell...